menu
    • menu

    Company profile for Ethypharm

    Ethypharm-PSE
    News
    Acquisition Of Argatroban Business In Europe

    17 Jun 2024

    // PRESS RELEASE

    Ethypharm expands its Mesalazine (Etiasa®) Portfolio in China

    13 Jun 2024

    // PRESS RELEASE

    Ethypharm ready to bring to patients world-leading digital therapies

    06 Apr 2024

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Ethypharm

    Contact Supplier

    Website

    CPhI Worldwide, Milan

    Booth #7G84

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/uprSlH6k144

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    Key Products KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Ethypharm

    Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

    Related CompaniesRelated Companies

    About

    Ethypharm is a European pharmaceutical company focused on CNS and Hospital injectables either through direct sales or through D&L.
    Ethypharm is also offering contract development and manufacturing (CDMO) services from formulation, clinical to scale up and commercial phases.
    Ethypharm is your CDMO partner for sterile forms (Ampoule, PFS, Vials, Lyo) and conventional (complex solid dosage forms and orals), using conventional API and High potent, Narcotics, Controlled drugs.
    Our expertise in Flashtab, Tmask, Nanosizing, Multicaps, Transmucosal, and Orodispersible technologies enables us to develop innovative formulations.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EthypharmFrance Flag
    Country
    Country
    France
    Address
    Address
    194 Bureaux de la Colline, Batiment D – 12eme etage, 92213 Saint-Cloud Cedex
    Telephone
    Telephone
    +33 0141121720
    Client Email
    Email
    info@ethypharm.com
    Client Website
    Website
    https://www.ethypharm.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ethypharm
    Twitter
    Twitter
    https://twitter.com/ethypharm
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    cphi-worldwide-milan-70313.png

    CPhI Worldwide, Milan

    Booth #7G84

    envelop Contact Supplier

    CPhI Worldwide, Milan

    Contact Supplier

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2023

    read-more

      https://www.pharmacompass.com/pdf/party/content/ethypharm-party-content-97467.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/ethypharm-party-content-79941.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate 2022

    read-more

      https://www.pharmacompass.com/pdf/party/content/ethypharm-party-content-79362.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Pharmaceutical Capabilities

    read-more

      https://www.pharmacompass.com/pdf/party/content/ethypharm-party-content-84782.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Acquisition Of Argatroban Business In Europe
    Acquisition Of Argatroban Business In Europe

    17 Jun 2024

    // PRESS RELEASE

    https://www.ethypharm.com/wp-content/uploads/2024/06/18-06-24-Press-Release-Argatroban-Ethypharm-Final.pdf

    PRESS RELEASE
    17 Jun 2024
    Share Share
    Ethypharm expands its Mesalazine (Etiasa®) Portfolio in China
    Ethypharm expands its Mesalazine (Etiasa®) Portfolio in China

    13 Jun 2024

    // PRESS RELEASE

    https://www.ethypharm.com/wp-content/uploads/2024/06/13062024_Group-PR_-Ethypharm-Expands-its-Mesalazine-Portfolio-in-China_FINAL-PR-NEWSWIRE.pdf

    PRESS RELEASE
    13 Jun 2024
    Share Share
    Ethypharm ready to bring to patients world-leading digital therapies
    Ethypharm ready to bring to patients world-leading digital therapies

    06 Apr 2024

    // PRESS RELEASE

    https://www.ethypharm.com/wp-content/uploads/2022/10/Agreement-Gaia-AG-EN.pdf

    PRESS RELEASE
    06 Apr 2024
    Share Share
    Ethypharm announces the Appointment of Xavier LASSERRE as CCO
    Ethypharm announces the Appointment of Xavier LASSERRE as CCO

    13 Jun 2023

    // PRESS RELEASE

    https://www.ethypharm.com/wp-content/uploads/2023/06/PR-Xavier-LASSERRE-appointed_CCO_Ethypharm-final.pdf

    PRESS RELEASE
    13 Jun 2023
    Share Share
    Aurora & Ethypharm Reaffirm their Commitment to Promote to Medical Cannabis
    Aurora & Ethypharm Reaffirm their Commitment to Promote to Medical Cannabis

    01 May 2023

    // PRESS RELEASE

    https://www.ethypharm.com/wp-content/uploads/2023/05/Aurora_Ethypharm_Extension-Pilot-Program_FINAL-1.pdf

    PRESS RELEASE
    01 May 2023
    Share Share
    Bruno Ultra BARCELOS is appointed Managing Director of Ethypharm UK
    Bruno Ultra BARCELOS is appointed Managing Director of Ethypharm UK

    31 Jan 2023

    // PRESS RELEASE

    https://www.ethypharm.com/wp-content/uploads/2023/01/Presse-release-_-Bruno-Ultra-BARCELOS-appointed-Managing-Director_Ethypharm-UK-_-EN.pdf

    PRESS RELEASE
    31 Jan 2023
    Share Share

    Services

    Discover the service capabilities from this company

    Drug Product Manufacturing

    Discover their expertise for : Drug Product Manufacturing

    API & Drug Product Development

    Discover their expertise for : API & Drug Product Development

    KEY SERVICES

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:

    Ethypharm full-view